Biologix was proud to participate in the Saudi Interstitial Lung Disease Conference (SILD 2026) in Jeddah on May 2nd.
We joined leading healthcare professionals to advance conversations on complex pulmonary diseases, with a focus on improving outcomes for patients with Pulmonary Hypertension associated with Interstitial Lung Disease (PH-ILD).
Our commitment to elevating standards of care across the region remains at the heart of everything we do.
